116 related articles for article (PubMed ID: 8104374)
1. Requirements of exogenous protein antigens for presentation to CD4+ T lymphocytes by MHC class II-positive APC.
Gradehandt G; Hampl J; Kleber N; Lobron C; Milbradt S; Schmidt B; Rüde E
Adv Exp Med Biol; 1993; 329():23-7. PubMed ID: 8104374
[No Abstract] [Full Text] [Related]
2. Proteases, processing, and thymic selection.
Cresswell P
Science; 1998 Apr; 280(5362):394-5. PubMed ID: 9575085
[No Abstract] [Full Text] [Related]
3. MHC class II-mediated antigen presentation by alloreactive rat CD4+ T cells does not induce regulatory properties.
Otto C; Heeg A; Kottenmeier S; Tiurbe GC; Thiede A; Ulrichs K
Transplant Proc; 2006 Apr; 38(3):755-6. PubMed ID: 16647463
[TBL] [Abstract][Full Text] [Related]
4. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
[TBL] [Abstract][Full Text] [Related]
5. The alloreactive and self-restricted CD4+ T cell response directed against a single MHC class II/peptide combination.
Kovalik JP; Singh N; Mendiratta SK; Martin WD; Ignatowicz L; Van Kaer L
J Immunol; 2000 Aug; 165(3):1285-93. PubMed ID: 10903728
[TBL] [Abstract][Full Text] [Related]
6. Exogenous antigens bind MHC class II first, and are processed by cathepsins later.
Sadegh-Nasseri S; Kim A
Mol Immunol; 2015 Dec; 68(2 Pt A):81-4. PubMed ID: 26254987
[TBL] [Abstract][Full Text] [Related]
7. High efficiency of endogenous antigen presentation by MHC class II molecules.
Calin-Laurens V; Forquet F; Lombard-Platet S; Bertolino P; Chrétien I; Trescol-Biémont MC; Gerlier D; Rabourdin-Combe C
Int Immunol; 1992 Oct; 4(10):1113-21. PubMed ID: 1336977
[TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility antigen class II expressing resting porcine T lymphocytes are potent antigen-presenting cells in mixed leukocyte culture.
Saalmüller A; Maurer S
Immunobiology; 1994 Feb; 190(1-2):23-34. PubMed ID: 8082885
[TBL] [Abstract][Full Text] [Related]
9. Alloreactive CD4 T cell activation in vivo: an autonomous function of the indirect pathway of alloantigen presentation.
Reed AJ; Noorchashm H; Rostami SY; Zarrabi Y; Perate AR; Jeganathan AN; Caton AJ; Naji A
J Immunol; 2003 Dec; 171(12):6502-9. PubMed ID: 14662850
[TBL] [Abstract][Full Text] [Related]
10. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation.
Li Y; Ke Y; Gottlieb PD; Kapp JA
J Leukoc Biol; 1994 Nov; 56(5):616-24. PubMed ID: 7525819
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo.
Beers C; Burich A; Kleijmeer MJ; Griffith JM; Wong P; Rudensky AY
J Immunol; 2005 Feb; 174(3):1205-12. PubMed ID: 15661874
[TBL] [Abstract][Full Text] [Related]
12. Antigen presentation and T cell development in H2-M-deficient mice.
Fung-Leung WP; Surh CD; Liljedahl M; Pang J; Leturcq D; Peterson PA; Webb SR; Karlsson L
Science; 1996 Mar; 271(5253):1278-81. PubMed ID: 8638109
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of antigen processing and major histocompatibility complex class II-restricted presentation.
Lich JD; Blum JS
Methods Mol Biol; 2001; 156():49-56. PubMed ID: 11068749
[No Abstract] [Full Text] [Related]
14. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
15. Luminal bacterial antigen-specific CD4+ T-cell responses in HLA-B27 transgenic rats with chronic colitis are mediated by both major histocompatibility class II and HLA-B27 molecules.
Qian BF; Tonkonogy SL; Balfour Sartor R
Immunology; 2006 Mar; 117(3):319-28. PubMed ID: 16476051
[TBL] [Abstract][Full Text] [Related]
16. [MHC class II restricted antigen presentation].
Hirata S; Nishimura Y
Nihon Rinsho; 2005 Apr; 63 Suppl 4():299-303. PubMed ID: 15861672
[No Abstract] [Full Text] [Related]
17. Direct observation of ligand recognition by T cells.
Irvine DJ; Purbhoo MA; Krogsgaard M; Davis MM
Nature; 2002 Oct; 419(6909):845-9. PubMed ID: 12397360
[TBL] [Abstract][Full Text] [Related]
18. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
McMenamin C; Holt PG
J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
[TBL] [Abstract][Full Text] [Related]
19. The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes.
Thompson JA; Srivastava MK; Bosch JJ; Clements VK; Ksander BR; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2008 Mar; 57(3):389-98. PubMed ID: 17724589
[TBL] [Abstract][Full Text] [Related]
20. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes.
Mellins E; Smith L; Arp B; Cotner T; Celis E; Pious D
Nature; 1990 Jan; 343(6253):71-4. PubMed ID: 1967485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
